Tag: Obesity

New Delhi: As multiple Indian pharma companies enter the semaglutide market and prices fall about 80 per cent from the innovator’s brand, doctors say the country is on the ...

The world’s biggest health threat may not be the next virus but a “tsunami” of obesity and diabetes, warned Peter Piot, world-renowned virologist who discovered Ebola and led the ...

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a “long-term” opportunity in India’s fast-evolving obesity and cardiometabolic therapy market, even as price competition ...

India is set to emerge as the next hub for semaglutide active pharmaceutical ingredient (API) after China, with top drugmakers building significant capacity to tap the booming global market ...

No matter where people live, and no matter how active they are, it’s what they eat that appears to drive obesity, according to a major new study. The study, ...

New Delhi: In his Independence Day address from the Red Fort, Prime Minister Narendra Modi issued a strong public health advisory, urging citizens to guard against the growing crisis ...

Model proved more accurate for people of European ancestryThe PRS model proved more accurate for people of European ancestry compared to South Asians. The model, created using genetic data ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.The medications still amount to around $500 per month for those ...

“With this approval, all six dosage options for Mounjaro (tirzepatide) will soon be available in India, supporting a more personalised approach to treatment and allowing healthcare professionals to tailor ...

CHENNAI: Danish drugs and insulin maker Novo Nordisk launched Wegovy, its latest and the much-awaited weight-loss drug -- a once‑a‑week semaglutide injection, in India today (June 24). The drug ...